Interview with Juan Basterra CEO of the company.
What is your differential value?
The pharmaceutical form, that is, the gastroresistant capsules of freeze-dried fecal microbiota, the administration in a single dose of 4 capsules and our ongoing phase III clinical trial in 21 hospitals in Spain.
And the great Mikrobiomik team because talent is always a differential value.
